Department of Medicine
Faculty Profiles by Division

Division of General Internal Medicine

Faculty Profiles
[Return To Index page]
photo Jane M. Liebschutz, MD, MPH, FACP

General Internal Medicine

Chief, Division of General Internal Medicine

Professor of Medicine with Tenure

Falk Professor in Ambulatory Care

Director, Center for Research on Health Care

Email: liebschutzjm@upmc.edu

Phone: 412-692-4821
Contact
Office: UPMC Montefiore Hospital, Suite 933W
200 Lothrop Street
Pittsburgh, PA 15213
 
Phone: 412-692-4821
Fax: 412-692-4825
E-mail: liebschutzjm@upmc.edu
Administrative Assistant:
Kathy Nosko
Email: noskoka@upmc.edu
Phone: 412-692-4821
Education and Training
Education
BA, East Asian Studies (China), Yale University, 1983
MD, Harvard Medical School, 1991
MPH, Boston University School of Public Health, Epidemiology and Biostatistics, 1998
Training
Internal Medicine Residency, Boston City Hospital, 1994
Preventive Medicine Residency, Boston University Medical Center, 1998
General Medicine Fellowship Program, Boston University Medical Center, 1998
Faculty Fellow, Prevention and Other Drug Abuse Faculty Development Program, Boston University Medical Center, 2001
Research Interest
Dr. Liebschutz’s research focuses on prevention and treatment of OUD in medical settings, with a focus on opioid prescribing for pain and treatment of OUD. She uses implementation science and health services research methods, including analysis of databases, survey research, intervention development, qualitative studies, and large randomized trials.

She has served as PI and co-investigator on multiple NIDA funded RO1 and U studies, including cohort studies and randomized controlled trials in inpatient, primary care, and HIV care settings. She is PI of the Appalachian Node of NIDA Clinical Trials Network. In this capacity she co-leads the Subthreshold Opioid Use Disorder Prevention (STOP) Trial, a cluster randomized trial (CRT) examining whether a nurse-care manager, brief PCP advice, and telephone health coaching can reduce risky opioid use. She also co-leads the Co-CARE Trial, a CRT testing whether a formal collaborative care intervention with nurse-care manager, health coaching, population management, contingency management, and addiction specialist consultation can reduce polysubstance use in primary care settings. She is also multi-PI of a cooperative NIDDK HEAL initiative trial, Pain Reduction and Opioid Medication Safety in ESRD (PROMISE) Study, examining pain treatment, including buprenorphine treatment, for patients on dialysis.

She founded and chairs Bridging Connections in Addiction Research at the University of Pittsburgh, a network of multi-disciplinary addiction researchers for collaborative research and training. She collaborates on studies examining real-world data on impact of medications for OUD, harm reduction methods, and emerging complications of the opioid and addiction epidemic. She also studies physician burnout and wellness.
Clinical Interest
Dr. Liebschutz manages a panel of primary care patients, including long-term management of substance use disorder. She also serves as consultant on the Addiction Medicine Consult Service (AMCS). In her capacity as Division Chief, she established the AMCS and greatly expanded the Internal Medicine Recovery Engagement Program (IMREP), a combined primary care and addiction medicine practice. She has supported low-barrier addiction care and harm reduction practices and is working on expanding these capacities into the future.
Educational Interest
Dr. Liebschutz’s current educational focus is on expanding clinical and research skills related to substance use and heath services research. She has students and residents rotate with her on the inpatient Addiction Medicine Consult service as well as in primary care. She is a national lecturer and educator on opioid prescribing and developed the website, www.opioidresources.org, a resource for opioid prescribing in the primary care setting.

She is PI of PittCATS, a NIDA-funded internal mentored K award program for promising junior faculty in addiction research at the University of Pittsburgh. She directs the Seminar On Addiction Research (SOAR) for post-docs and junior faculty. While at Boston University, she was PI or co-I of over 16 funded training grants from HRSA, AHRQ, American Cancer Society, and NIH (NIDA).
Publications
For my complete bibliography, Click Here.
Selected Publications:
Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, Stein M. Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial. JAMA Internal Medicine. 2014; 174(8): 1369-1376.
Liebschutz, J. M., Xuan, Z., Shanahan, C. W., LaRochelle, M., Keosaian, J., Deers, D., Guara, G., O'Connor, K., Alford, D. P., Parker, V., Weiss, R. D., Samet, J. H., Crosson, J., Cushman, P.A.**, Lasser, K. E. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Trial. JAMA Intern Med. 2017; 177(9): 1265-1272.
Merlin, J. S., Young, S. R., Starrels, J. L., Azari, S., Edelman, E. J., Pomeranz, J., Roy, P., Saini, S., Becker, W. C., Liebschutz, J. M. Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: a Delphi study. JGIM. 2018; 33(2): 166-176.
Stein, M. D., Phillips, K. T., Herman, D. S., Keosaian, J., Stewart, C., Anderson, B. J., Weinstein, Z., Liebschutz, J. M. Skin Cleaning among Hospitalized Persons Who Inject Drugs: A randomized controlled trial. Addiction. 2021; 116(5): 1122-1130.
Sponsored Research/Activities
Title: Developing an intervention to address opioid stigma in cancer survivors: formative work
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: UG1 DA049436
Start Year: 2020
End Year: 2021
Title: Appalachian Node
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: UG1
Start Year: 2019
End Year: 2024
Title: University of Pittsburgh Collaboration in Addiction Training Scholars (PittCATS) Program
Role: Co-Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: K12 DA050607
Start Year: 2020
End Year: 2025
Title: Consensus-based algorithms to address opioid misuse behaviors among individuals prescribed long-term opioid therapy: developing implementation strategies and pilot testing
Role: Co-Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: R34 DA050004
Start Year: 2020
End Year: 2023
Title: CDC PDMP OD2A Predictive Analytics Project
Role: Co-Investigator
Funding Agency: PA Department of Health / Center for Disease Control
Grant Number: RES
Start Year: 2020
End Year: 2022
Title: Implementing Prediction Models to Improve Opioid Risk
Role: Co-Investigator
Funding Agency: Richard King Mellon Foundation
Grant Number: RES 9909
Start Year: 2020
End Year: 2022
Title: Evaluation of the Efficacy and Mechanism of a Novel Intervention for Chronic Pain Tailored to People Living with HIV
Role: Co-Investigator
Funding Agency: National Institute of Mental Health
Grant Number: R01 MH115754
Start Year: 2018
End Year: 2023
Notable Achievements
Fellow, American College of Physicians, 2003
Executive Leadership in Academic Medicine (ELAM) Program, Drexel University, 2019
Anderson Spickard, Jr. Excellence in Mentorship Award, AMERSA, 2023

Division Websites

Cardiology

Endocrinology and Metabolism

Gastroenterology, Hepatology and Nutrition

General Internal Medicine

Geriatric Medicine
Hematology/Oncology

Infectious Diseases

Pulmonary, Allergy and Critical Care Medicine

Renal-Electrolyte

Rheumatology and Clinical Immunology

Contact

Department of Medicine
1218 Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261
Email:  chairoff@pitt.edu
Phone:  412-648-9636
Copyright © 2018 Department of Medicine / University of Pittsburgh School of Medicine
Site maintained by Medicine Technology Services MTS@PITT.EDU